POSTPARTUM DEWORMING AND INFANT GROWTH

POSTPARTUM DEWORMING: A NOVEL WAY TO IMPROVE BREASTFEEDING AND OPTIMIZE INFANT GROWTH

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

REPEC

Registry ID

PER-028-13

Enrollment

2020

Registered

2014-01-24

Start date

2013-08-01

Completion date

Unknown

Last updated

2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Albendazole single-dose 400 mg tablet. large-scale deworming applications. The participants (505 women) in group 1 will receive albendazole after delivery and the participants (505 women) in group 2

Eligibility

Sex/Gender

All

Age

1 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) deliver at Hospital Iquitos; 2) they are likely to reside in Iquitos or a neighbouring area for the next 24 months; and 3) they are able to communicate in Spanish

Exclusion criteria

Exclusion criteria: 1) deliver multiples; 2) they deliver a stillborn or an infant with a serious congenital medical condition; and 3) they are transferred to another hospital prior to discharge.

Countries

Peru

Contacts

Public ContactNorma Lidsky Pezo

ASOCIACION CIVIL SELVA AMAZONICA

lpezo@acsaperu.org51 65 236277 Ext 125

Outcome results